Skip to content

Drug interactions

Desogestrel-ethinyl estradiol + Letermovir

Severity: Minor

Desogestrel-ethinyl estradiol and Letermovir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir inhibits CYP3A and may increase exposure to the active metabolite of desogestrel. It may also affect ethinyl estradiol levels, and the net effect on contraceptive efficacy is unlikely to be clinically important.

What this interaction means in plain words

Desogestrel-ethinyl estradiol and Letermovir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Desogestrel-ethinyl estradiol belongs to Endocrine; Letermovir belongs to Anti Virals.

Evidence level: Low

Why it happens

Letermovir inhibits CYP3A4, reducing hormone metabolism, while it may also induce other enzymes.

What to do

No routine dose change is required. Monitor for hormonal adverse effects during letermovir therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Desogestrel-ethinyl estradiol and Letermovir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Desogestrel-ethinyl estradiol with Letermovir?

MediHelp rates the interaction as minor. Desogestrel-ethinyl estradiol and Letermovir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Letermovir inhibits CYP3A and may increase exposure to the active metabolite of desogestrel. It may also affect ethinyl estradiol levels, and the net effect on contraceptive efficacy is unlikely to be clinically important.

How serious is the interaction between Desogestrel-ethinyl estradiol and Letermovir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is required. Monitor for hormonal adverse effects during letermovir therapy.

What other medicines interact with Desogestrel-ethinyl estradiol?

MediHelp also lists interactions of Desogestrel-ethinyl estradiol with, for example, Fezolinetant, Aminocaproic acid, Amobarbital. The full list is on the Desogestrel-ethinyl estradiol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in